Facilities
The CFDD’s UK GLP Monitoring Authority accredited preclinical facility is scheduled to “Go Live January 2028”.
The lab will allow non-clinical animal safety studies to be conducted according to the appropriate UK quality standards and regulatory requirements. These standards ensure that data submitted to regulatory agencies is reliable, reproducible, and scientifically valid.
Our facilities quality system is designed to ensure integrity and traceability of nonclinical study data for regulatory agencies such as the MHRA, FDA, EPA, EMA, and OECD member countries for studies supporting the safety of pharmaceuticals and other regulated products.
The facility will initially focus on small animal acute dosing toxicology studies. It will generate high-quality, trustworthy data that allow regulators to make informed decisions about the safety of new products.
